Remove 2003 Remove Licensing Remove Patent Application Remove Registering Trademarks
article thumbnail

Understanding Freedom to Operate (FTO) Concerning IP & Patents

Kashishipr

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. Patents have a limited protection period. Overcoming Obstacles . Bottom Line.

IP 105
article thumbnail

Saving your Mark from Trademark Genericide

Kashishipr

Genericism is not a free license to use a competitor’s trademark. Reasons behind Trademark Genericide. Interestingly, in these cases, the trademark owner itself/himself misused the trademark as the generic name of the product in advertising and Patent Applications.

Trademark 105
article thumbnail

SpicyIP Weekly Review (August 7- August 13)

SpicyIP

Other Posts Timelines under Rule 138 of Patent Rules are to be interpreted strictly and there cannot be any leeway under Rule 49.6 of PCT Regulations, says Delhi High Court The DHC ruled that timelines for filing national phase applications cannot be extended, in light of India’s reservation to the PCT Regulations on this.